# TXMD catalysts: TherapeuticsMD, Inc. PDUFA dates and FDA events

Canonical: https://sec-api.dev/companies/txmd/catalysts

> TherapeuticsMD, Inc. (TXMD) has no upcoming catalysts in this calendar. The latest recorded is the TherapeuticsMD, Inc. earnings report, November 13, 2026.

Data as of November 16, 2026 (snapshot 20261116T222116Z). Every date quotes the SEC filing or FDA page it came from. Date precision: exact day.

**Free:** every drug page and the next 30 days of the FDA calendar, no account. Calendar API, alerts when a date moves, and full history: https://sec-api.dev/pricing . Free API key: https://sec-api.dev/sign-up?ref=ai-claudebot

## Verified answer

### What are the upcoming FDA catalysts for TXMD?

TherapeuticsMD, Inc. (TXMD) has no upcoming catalysts in this calendar. The latest recorded is the TherapeuticsMD, Inc. earnings report, November 13, 2026. Press release filed with the SEC (EX-99): "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 13, 2026, ENTITLED "THERAPEUTICSMD ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS."" [Calendar and source filings](https://sec-api.dev/companies/txmd/catalysts)

Source: Press release filed with the SEC (EX-99), accession 0001213900-26-119681, https://www.sec.gov/Archives/edgar/data/25743/000121390026119681/ea031220401ex99-1.htm (retrieved 2026-11-14). Last confirmed 2026-11-13. Cite: https://sec-api.dev/companies/txmd/catalysts#answer

## Company

| Field | Value |
| --- | --- |
| Name | TherapeuticsMD, Inc. |
| Ticker | TXMD (Nasdaq) |
| SEC CIK | 25743 |
| SIC | 2834 |
| SEC filings | https://sec-api.dev/companies/txmd |

## Catalysts

| Date | Event | Ticker | Indication | Status | Source sentence |
| --- | --- | --- | --- | --- | --- |
| May 5, 2017 | [Imvexxy (estradiol) complete response letter (CRL)](https://sec-api.dev/pdufa/estradiol) | TXMD |  | completed, complete response letter | "We have completed our review of this application, as amended, and have determined that we cannot approve this application in its present form." ([FDA complete response letter database](https://api.fda.gov/transparency/crl.json?search=file_name:%22208564_2018_Orig1s000OtherActionLtrs.pdf%22)) |
| November 12, 2024 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 12, 2024, ENTITLED "THERAPEUTICSMD ANNOUNCES THIRD QUARTER 2024 FINANCIAL RESULTS"" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390024096804/ea022059301ex99-1_therape.htm)) |
| March 27, 2025 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED MARCH 27, 2025, ENTITLED THERAPEUTICSMD ANNOUNCES FULL YEAR 2024 FINANCIAL RESULTS" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000101376225003407/ea023520001ex99-1_therap.htm)) |
| May 13, 2025 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED MAY 13, 2025, ENTITLED "THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2025 FINANCIAL RESULTS"" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390025042663/ea024198601ex99-1_therap.htm)) |
| August 12, 2025 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED AUGUST 12, 2025, ENTITLED "THERAPEUTICSMD ANNOUNCES SECOND QUARTER 2025 FINANCIAL RESULTS."" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390025074975/ea025234801ex99-1_therap.htm)) |
| November 12, 2025 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 12, 2025, ENTITLED "THERAPEUTICSMD ANNOUNCES THIRD QUARTER 2025 FINANCIAL RESULTS."" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390025109479/ea026541601ex99-1_therape.htm)) |
| March 30, 2026 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "30, 2026 -- TherapeuticsMD, Inc. ("TherapeuticsMD" or the "Company") (NASDAQ: TXMD), a company that owns rights to pharmaceutical royalties, today reported financial results for the full year ended December 31, 2025." ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390026036519/ea028323901ex99-1.htm)) |
| May 2, 2026 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED MAY 12, 2026, ENTITLED "THERAPEUTICSMD ANNOUNCES FIRST QUARTER 2026 FINANCIAL RESULTS."" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390026055070/ea028977601ex99-1.htm)) |
| August 11, 2026 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED AUGUST 11, 2026, ENTITLED "THERAPEUTICSMD ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS."" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390026087756/ea029897901ex99-1.htm)) |
| November 13, 2026 | [TherapeuticsMD, Inc. earnings report](https://sec-api.dev/companies/txmd/catalysts) | TXMD |  | completed | "PRESS RELEASE FROM THERAPEUTICSMD, INC., DATED NOVEMBER 13, 2026, ENTITLED "THERAPEUTICSMD ANNOUNCES SECOND QUARTER 2026 FINANCIAL RESULTS."" ([Press release filed with the SEC (EX-99)](https://www.sec.gov/Archives/edgar/data/25743/000121390026119681/ea031220401ex99-1.htm)) |

## Drugs

- [Imvexxy (estradiol)](https://sec-api.dev/pdufa/estradiol): 

## Feeds and downloads

- Subscribe (iCal): https://sec-api.dev/companies/txmd/catalysts.ics
- Next 30 days as CSV: https://sec-api.dev/fda-calendar.csv . JSON: https://sec-api.dev/fda-calendar.json . All events (iCal): https://sec-api.dev/fda-calendar.ics
- New or moved PDUFA dates: https://sec-api.dev/pdufa-dates/feed.xml (RSS), https://sec-api.dev/pdufa-dates/feed.json (JSON Feed)
- FDA approvals: https://sec-api.dev/fda-approvals-today/feed.xml (RSS), https://sec-api.dev/fda-approvals-today/feed.json (JSON Feed)
- License: CC BY 4.0 for the public 30-day window (https://sec-api.dev/biotech/license.txt). Full history: https://sec-api.dev/pricing

## Cite this page

sec-api.dev. "TXMD catalysts: TherapeuticsMD, Inc. PDUFA dates and FDA events." Biotech catalyst calendar, data as of November 16, 2026 (snapshot 20261116T222116Z). https://sec-api.dev/companies/txmd/catalysts

```bibtex
@misc{secapidev_companies_txmd_catalysts_20261116,
  title        = {TXMD catalysts: TherapeuticsMD, Inc. PDUFA dates and FDA events},
  author       = {{sec-api.dev}},
  year         = {2026},
  month        = {nov},
  howpublished = {\url{https://sec-api.dev/companies/txmd/catalysts}},
  note         = {Biotech catalyst calendar, data as of 2026-11-16, snapshot 20261116T222116Z. Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source.}
}
```

```json
{"type":"dataset","id":"secapidev_companies_txmd_catalysts_20261116","title":"TXMD catalysts: TherapeuticsMD, Inc. PDUFA dates and FDA events","publisher":"sec-api.dev","URL":"https://sec-api.dev/companies/txmd/catalysts","issued":{"date-parts":[[2026,11,16]]},"version":"20261116T222116Z","license":"https://creativecommons.org/licenses/by/4.0/","note":"Compiled from SEC EDGAR filings, FDA and ClinicalTrials.gov; each date quotes its source."}
```

---
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Food and Drug Administration or the U.S. Securities and Exchange Commission. Dates are as stated by sponsors and FDA; the FDA can act before or after a target date. Not investment advice.
